T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNR
1976
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.18M | ﹤0.01% |
66,562
-2,701
| -4% | -$47.7K |
|
|
NAV
1977
DELISTED
Navistar International
NAV
| $1.17M | ﹤0.01% |
26,583
+15
| +0.1% | +$661 |
|
|
VG
1978
DELISTED
Vonage Holdings Corporation
VG
| $1.17M | ﹤0.01% |
98,883
-6,704
| -6% | -$87.3K |
|
1979
8x8 Inc
EGHT
$290M
| $1.16M | ﹤0.01% |
35,886
-489
| -1% | -$16.9K |
|
1980
Federated Hermes
FHI
$4.7B
| $1.16M | ﹤0.01% |
37,107
+992
| +3% | +$29.1K |
|
1981
Associated Banc-Corp
ASB
$6.07B
| $1.16M | ﹤0.01% |
54,289
-1,388
| -2% | -$28.1K |
|
1982
First Bancorp
FBP
$4.46B
| $1.16M | ﹤0.01% |
102,890
-36
| -0% | -$378 |
|
|
FIRY
1983
Firy Inc
FIRY
$156M
| $1.16M | ﹤0.01% |
+3,035
| New | +$1.74M |
|
|
SI
1984
DELISTED
Silvergate Capital Corporation
SI
| $1.15M | ﹤0.01% |
8,119
+1,060
| +15% | +$126K |
|
|
AVTA
1985
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.15M | ﹤0.01% |
69,042
-33
| -0% | -$554 |
|
|
MCHB
1986
Mechanics Bancorp
MCHB
$3.8B
| $1.15M | ﹤0.01% |
26,039
-7,002
| -21% | -$291K |
|
1987
Worthington Enterprises
WOR
$2.78B
| $1.15M | ﹤0.01% |
27,764
+396
| +1% | +$15.1K |
|
|
CMAX
1988
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $1.15M | ﹤0.01% |
+3,158
| New | +$1.33M |
|
1989
CalciMedica
CALC
$19.1M
| $1.15M | ﹤0.01% |
+14,745
| New | +$4.41M |
|
1990
Peapack-Gladstone Financial
PGC
$822M
| $1.14M | ﹤0.01% |
36,926
+3,021
| +9% | +$82.9K |
|
1991
M/I Homes
MHO
$3.82B
| $1.13M | ﹤0.01% |
19,146
-3,934
| -17% | -$204K |
|
1992
Ares Capital
ARCC
$14.3B
| $1.12M | ﹤0.01% |
60,000
| – | – |
|
|
SGMO
1993
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.12M | ﹤0.01% |
89,381
-51,389
| -37% | -$692K |
|
1994
Liberty Latin America Class C
LILAK
$1.67B
| $1.12M | ﹤0.01% |
94,772
+27,527
| +41% | +$301K |
|
1995
IAMGOLD
IAG
$10.3B
| $1.12M | ﹤0.01% |
375,386
+122,575
| +48% | +$405K |
|
|
USCR
1996
DELISTED
U S Concrete, Inc.
USCR
| $1.11M | ﹤0.01% |
15,205
+5,657
| +59% | +$305K |
|
1997
Coca-Cola Europacific Partners
CCEP
$47.3B
| $1.11M | ﹤0.01% |
21,351
-7,700
| -27% | -$391K |
|
1998
Otter Tail
OTTR
$3.87B
| $1.11M | ﹤0.01% |
24,109
-1,000
| -4% | -$42.8K |
|
|
ARNC
1999
DELISTED
Arconic Corporation
ARNC
| $1.11M | ﹤0.01% |
43,817
+14,926
| +52% | +$401K |
|
|
SJI
2000
DELISTED
South Jersey Industries, Inc.
SJI
| $1.11M | ﹤0.01% |
49,219
+723
| +1% | +$17.1K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.